204 related articles for article (PubMed ID: 25786392)
1. Natural and synthetic compound anti-Trichomonas vaginalis: an update review.
Vieira Pde B; Giordani RB; Macedo AJ; Tasca T
Parasitol Res; 2015 Apr; 114(4):1249-61. PubMed ID: 25786392
[TBL] [Abstract][Full Text] [Related]
2. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
[TBL] [Abstract][Full Text] [Related]
3. 20S Proteasome as a Drug Target in Trichomonas vaginalis.
O'Donoghue AJ; Bibo-Verdugo B; Miyamoto Y; Wang SC; Yang JZ; Zuill DE; Matsuka S; Jiang Z; Almaliti J; Caffrey CR; Gerwick WH; Eckmann L
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451503
[TBL] [Abstract][Full Text] [Related]
4. In vitro effects of various plants extracts on the growth of Trichomonas vaginalis.
Sharafi SM; Yousefi M; Yousefi HA; Asghari G; Darani HY
Infect Disord Drug Targets; 2013 Oct; 13(5):322-7. PubMed ID: 24712672
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in anti-Trichomonas research: An update review.
Bala V; Chhonker YS
Eur J Med Chem; 2018 Jan; 143():232-243. PubMed ID: 29175675
[TBL] [Abstract][Full Text] [Related]
6. Anti-Trichomonas vaginalis activity of synthetic lipophilic diamine and amino alcohol derivatives.
Giordani RB; De Almeida MV; Fernandes E; França da Costa C; De Carli GA; Tasca T; Zuanazzi JA
Biomed Pharmacother; 2009 Sep; 63(8):613-7. PubMed ID: 19013752
[TBL] [Abstract][Full Text] [Related]
7. Anti-Trichomonas vaginalis activity from triterpenoid derivatives.
Innocente AM; Vieira Pde B; Frasson AP; Casanova BB; Gosmann G; Gnoatto SC; Tasca T
Parasitol Res; 2014 Aug; 113(8):2933-40. PubMed ID: 24880238
[TBL] [Abstract][Full Text] [Related]
8. Medicinal plants and their isolated compounds showing anti-Trichomonas vaginalis- activity.
Mehriardestani M; Aliahmadi A; Toliat T; Rahimi R
Biomed Pharmacother; 2017 Apr; 88():885-893. PubMed ID: 28178618
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro and in vivo biological evaluation of substituted nitroquinoxalin-2-ones and 2,3-diones as novel trichomonacidal agents.
Ibáñez-Escribano A; Reviriego F; Nogal-Ruiz JJ; Meneses-Marcel A; Gómez-Barrio A; Escario JA; Arán VJ
Eur J Med Chem; 2015 Apr; 94():276-83. PubMed ID: 25771033
[TBL] [Abstract][Full Text] [Related]
10. Antitrichomonal activity and docking analysis of thiazole derivatives as TvMP50 protease inhibitors.
Mena-Rejón G; Pérez-Navarro Y; Torres-Romero JC; Vázquez-Carrillo L; Carballo RM; Arreola R; Herrera-España Á; Arana-Argáez V; Quijano-Quiñones R; Fernández-Sánchez JM; Alvarez-Sánchez ME
Parasitol Res; 2021 Jan; 120(1):233-241. PubMed ID: 33073325
[TBL] [Abstract][Full Text] [Related]
11. Screening and bioguided fractionation of Amaryllidaceae species with anti-Trichomonas vaginalis activity.
Vieira Pde B; Giordani RB; De Carli GA; Zuanazzi JA; Tasca T
Planta Med; 2011 Jul; 77(10):1054-9. PubMed ID: 21308614
[TBL] [Abstract][Full Text] [Related]
12. Challenges and Persistent Questions in the Treatment of Trichomoniasis.
de Brum Vieira P; Tasca T; Secor WE
Curr Top Med Chem; 2017; 17(11):1249-1265. PubMed ID: 27697044
[TBL] [Abstract][Full Text] [Related]
13. Trichomoniasis and its treatment.
Nanda N; Michel RG; Kurdgelashvili G; Wendel KA
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):125-35. PubMed ID: 16441214
[TBL] [Abstract][Full Text] [Related]
14. Trichomoniasis: evaluation to execution.
Harp DF; Chowdhury I
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):3-9. PubMed ID: 21440359
[TBL] [Abstract][Full Text] [Related]
15. Anti-Trichomonas vaginalis activity of chalcone and amino-analogues.
Trein MR; Rodrigues E Oliveira L; Rigo GV; Garcia MAR; Petro-Silveira B; da Silva Trentin D; Macedo AJ; Regasini LO; Tasca T
Parasitol Res; 2019 Feb; 118(2):607-615. PubMed ID: 30535524
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic activities of nitrothiazoles against trichomonads.
Hof H; Müller KM; Schrank W; Schweizer EH; Zak O
Arzneimittelforschung; 1987 Mar; 37(3):306-9. PubMed ID: 3496102
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.
Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD
J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365
[TBL] [Abstract][Full Text] [Related]
18. A review study on the anti-trichomonas activities of medicinal plants.
Hashemi N; Ommi D; Kheyri P; Khamesipour F; Setzer WN; Benchimol M
Int J Parasitol Drugs Drug Resist; 2021 Apr; 15():92-104. PubMed ID: 33610966
[TBL] [Abstract][Full Text] [Related]
19. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
Meites E; Gaydos CA; Hobbs MM; Kissinger P; Nyirjesy P; Schwebke JR; Secor WE; Sobel JD; Workowski KA
Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S837-48. PubMed ID: 26602621
[TBL] [Abstract][Full Text] [Related]
20. In vitro trichomonacidal activity and preliminary in silico chemometric studies of 5-nitroindazolin-3-one and 3-alkoxy-5-nitroindazole derivatives.
Ibáñez-Escribano A; Nogal-Ruiz JJ; Gómez-Barrio A; Arán VJ; Escario JA
Parasitology; 2016 Jan; 143(1):34-40. PubMed ID: 26525913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
